Skip to search.
 TSX Up 0.18% TSX Ventures  0.00%
Streaming
Ticker Tape: On

Cell Therapeutics, Inc. (CTIC)

-NasdaqCM
3.25 Down 0.08(2.40%) 1:35PM EDT - Nasdaq Real Time Price
Add to Portfolio
Prev Close:3.33
Open:3.30
Bid:3.23 x 11400
Ask:3.24 x 12600
1y Target Est:4.83
Beta:1.51
Next Earnings Date:29-Apr-14CTIC Earnings announcement
Day's Range:3.21 - 3.31
52wk Range:0.97 - 4.25
Volume:1,423,006
Avg Vol (3m):5,120,180
Market Cap:457.66M
P/E (ttm):N/A
EPS (ttm):-0.44
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Must Read

Comparison

Symbol% ChgMkt Cap
CTICDown 2.40%457.66M
BMYDown 0.19%83.99B
RHHBYUp 0.03%123.21B
SNYDown 0.37%140.50B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):13.52
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.47
Quarterly EPS Est (Mar-14) :-0.17
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Cell Therapeutics, Inc., a biopharmaceutical company, is engaged in the acquisition, development, and commercialization of treatments for cancer. It primarily focuses on the commercialization of PIXUVRI, an aza-anthracenedione derivative, which is... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback